Abstract
This Frost & Sullivan research service titled Advances in Biomarkers provides
an overview of emerging technologies and their applications in disease
diagnosis, drug discovery and development, personalized medicine etc., along
with key drivers, restraints and analysis of trends witnessed in the biomarker
industry. In this research, Frost & Sullivan' s expert analysts thoroughly
examine the following technologies: genomics, proteomics, metabolomics, and
systems biology.